January $3.2 Million Sales Beats Previously Announced High in November of $1.95 Million

Cleveland, OH -- (ReleaseWire) -- 02/21/2019 -- Innovest Global Inc. (OTCMARKETS:IVST), a diversified Industrial Company, today announced it generated record gross sales in January 2019 of $3.2 million.

Other notable events from January:

A Fortune 500 client expanded its sales contract by 30%, adding $600,000 per year.

One of Innovest's new holdings (Authority National Supply) signed four new members expected to add $5.2 million in gross sales in 2019; prior to Innovest's ownership there had been only one new member added in the previous two years.

-Innovest Electric Solutions signed a $1.1 million contract for a NYSE listed client.

Employee base has grown from seven in January 2018, to 85 in January 2019.

-Total Current Assets $6.7 million.

-Cash balance $825,000.

-Signed a Letter of Intent to acquire a retail auto dealer which generates $30 million sales and commensurate profits.

In 2018 Innovest generated $7.8 million gross sales with $2.1 million gross profit, and distributed its annual letter to shareholders in January.

"Innovest continues to grow sales rapidly and is focused on the growth of its current Industrial companies, while exploring additional acquisitions that management feels could add significant shareholder value. Diversification into Biotechnology is also expected to result in progress this year both from StemVax and other efforts," said Dan Martin, Innovest's founder, Chairman, and Chief Executive Officer.

About Innovest Global, Inc.
Innovest Global, Inc. (OTC Markets: IVST) has operations in Industrials (commercial and industrial products and services, energy, construction, and building materials ) and diversified holdings in biotechnology. The primary growth strategy of Innovest Global Inc is to acquire existing companies in a select few industries and attract new customers in cost effective ways. Currently, Innovest Global Inc has a Commercial & Industrial Division, a Biotechnology & Health Services Division, and a Construction & Building Materials Division.

For more information, please visit: http://www.innovestglobal.com, and follow us on Twitter and Facebook @innovestglobal.

For more information, please visit: http://www.innovestglobal.com, and follow us on Twitter @innovestglobal.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the OTC Markets. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Contact Information

Corporate Office:
(216) 815-1122
info@innovestglobal.com
Facebook and Twitter @innovestglobal

Public Relations Consultant:
Paul Knopick
Pknopick@eandecommunications.com
940.262.3584

Investor Relations:
Stephen Hart
Hayden IR
(917) 658-7878

For more information on this press release visit: http://www.releasewire.com/press-releases/innovest-global-inc-otcmarketsivst-update-january-revenue-highest-1155407.htm

For Innovest, the second half of 2018 was marked by significant revenue growth and large, notable clients

Cleveland, OH -- (ReleaseWire) -- 01/02/2019 -- Innovest Global Inc. (OTCMarkets:IVST) (the "Company" or "Innovest"), a conglomerate with operations in commercial and industrial products and services, biotechnology, construction and building materials, won a $1.1 million contract with SIFCO Industries. The contract utilizes new technology introduced by Innovest in 2018, which is projected to be a key component of Energy Group growth in 2019.

The technology provides for estimated reduction of client operating costs by $400,000 per year in this case, with a lifespan of more than 20 years, to be implemented by reconstructing electric infrastructure at client facilities. The contract was signed the last week in December, and the project will be completed in the first half of 2019.

"Our Damon Mintz had the vision to go after this technology for us in 2018 while he was running our Energy Division, and he led our successful effort in the past few weeks to bring it entirely in-house. It provides our industrial clients a significant return on investment while being a profitable solution for us to execute. This is exactly the type of differentiation, innovation, and growth offering we pursue at Innovest," said Dan Martin, Innovest's founder, Chairman and Chief Executive Officer. "The Shepherd Energy team secured the client proposal, and will manage this project. Our entire energy team deserves credit for amazing execution in 2018, and positioning the division for significant growth in 2019."

For Innovest, the second half of 2018 was marked by significant revenue growth and large, notable clients. Look for much more information to come soon about 2018 results, 2019 plans, and important developments.

About Innovest Global, Inc.
Innovest Global, Inc. (OTC Markets: IVST) is a conglomerate with operations in commercial and industrial products and services, energy, biotechnology, and health services. Our primary growth strategy is to acquire existing companies in a select few industries, and attract new customers in cost effective ways. Currently, we have a Commercial & Industrial Division, a Biotechnology Division, and a Construction & Building Materials Division.

For more information, please visit: http://www.innovestglobal.com, and follow us on Twitter and Facebook @innovestglobal.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the OTC Markets. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Contact Information
Corporate Office:
(216) 815-1122
info@innovestglobal.com
Twitter @innovestglobal

Investor Relations:
Hayden IR
(917) 658-7878
hart@haydenir.com

For more information on this press release visit: http://www.releasewire.com/press-releases/innovest-energy-group-wins-1-million-contract-deploy-1115142.htm

Innovest has now completed seven transactions to round out a business platform which features $50 million in annual revenue run-rate

Cleveland, OH -- (ReleaseWire) -- 12/26/2018 -- Innovest Global Inc. (OTCMarkets:IVST) (the "Company" or "Innovest"), a conglomerate with operations in commercial and industrial products and services, biotechnology, and building materials, announces that it closed the acquisition of Midwest Curtainwalls ("Midwest") on Friday afternoon.

Innovest has now completed seven transactions to round out a business platform which features $50 million in annual revenue run-rate, from two operating divisions; as well as a Biotech Division, which owns an interest in a developmental brain cancer vaccine. Ninety percent of that revenue has been acquired in the last 45 days. The initial operating companies have grown by approximately 50% since acquisition, and have integrated synergistically.

Dan Martin, Innovest's founder, Chairman, and Chief Executive Officer started Innovest just one year ago. "We've added tremendous intrinsic value to Innovest, while issuing minimal stock, no long-term debt, no risky financing transactions, and a focused effort to grow those assets once acquired. Our 2019 plan will be announced soon and involves all of the tools and progress we will need to supercharge our growth and capture that value for stockholders," he said. "Merry Christmas and Happy Holidays to all of our stockholders, which we appreciate greatly for their confidence. Their support has given us the momentum and opportunity to grow, and I'm extremely thankful to our team for serving that opportunity to an amazing level."

John Yenges, who has been running Midwest as EVP is now it's President. "The acquisition was enthusiastically received by our client pipeline and our team, and I'm excited to couple Midwest with the philosophies and opportunities Innovest provides. I expect spectacular results," said John Yenges. Dan Martin stated, "John doesn't just 'fit in' with Innovest, he adds to Innovest. He brings a unique skillset, his own high energy, great ideas, and a motivated team. He's a true professional and a wonderful person and we are all thrilled to work with him and the people at Midwest".

More about Midwest:

Midwest (click here for their website) has been in business since 1959 and is an industry leader. Their work has international appeal having done major projects in the United States, Barcelona Spain, London England, and Hong Kong. Midwest will add to our Construction & Building Materials Division. They generate eight-figures in annual revenue from specialty commercial construction contracts. This transaction is our most profitable acquisition to-date. It requires the issuance of 2 million restricted common shares of stock with a two-year guarantee, a ten-percent profit sharing arrangement based 2019 booked contracts, and the assumption of approximately $500,000 in ongoing standard banking obligations which are current and in good standing. Midwest is cash-flow positive in the low seven-figure range.

About Innovest Global, Inc.
Innovest Global, Inc. (OTC Markets: IVST) is a conglomerate with operations in commercial and industrial products and services, energy, biotechnology, and health services. Our primary growth strategy is to acquire existing companies in a select few industries, and attract new customers in cost effective ways. Currently, we have a Commercial & Industrial Division, a Biotechnology Division, and a Construction & Building Materials Division.

For more information, please visit: http://www.innovestglobal.com, and follow us on Twitter and Facebook @innovestglobal.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the OTC Markets. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Contact Information
Corporate Office:
(216) 815-1122
info@innovestglobal.com
Twitter @innovestglobal

Investor Relations:
Hayden IR
(917) 658-7878
hart@haydenir.com

For more information on this press release visit: http://www.releasewire.com/press-releases/innovest-global-acquires-midwest-curtainwalls-adding-10-million-1112143.htm

This contract will further boost revenue for Innovest’s Commercial & Industrial Division and creates a stepping stone for additional business in 2019

Cleveland, OH -- (ReleaseWire) -- 11/27/2018 -- Innovest Global Inc. (OTCMarkets:IVST) (the "Company" or "Innovest"), a conglomerate with operations in commercial and industrial products and services, biotechnology, and construction & building materials, is excited to announce that Chagrin Safety Supply (CSS), an Innovest Global Company, just closed a four-year contract extension providing safety supplies to the University Hospital and Case Medical Center administration buildings in Cleveland, Ohio. This contract will further boost revenue for Innovest's Commercial & Industrial Division and creates a stepping stone for additional business in 2019. CSS revenue for 2018 exceeds 2017 revenue, and has benefited from larger contracts, including the recently announced six-figure order of HAZMAT boots delivered to the United States Navy.

For Innovest's acquired companies, 2018 has been marked by high-revenue contracts with large and very notable clients. Increased revenue after acquisition is a result of both successful integration into the Innovest business model, and Innovest being very appealing as a vendor to large clients.

University Hospitals are ranked number 2 in Ohio and consistently rank in the Top 50 nationally, according to the organization 'U.S. News' which evaluates each hospital in up to 16 medical specialties. In most specialties, the top 50 hospitals nationally are numerically ranked and the University Hospitals Cleveland are ranked in the top 50 in almost all categories.

"Case Medical Center is a great client and I'm thrilled that since coming under the Innovest umbrella, they added two more facilities in addition to the buildings we already service. This contract represents the confidence and satisfaction of our supply agreement and I'm pleased that they have extended our relationship four years," said Chagrin Safety Supply president, Bill Oler.

"The fact that University Hospitals and in particular, Case Medical Center trust us to maintain the new standards set by OSHA in 2015 for workplace first aid requirements illustrates the credibility of our Safety Group. The burden and liability is on the employer to identify workplace hazards and they trust our team to maintain these high standards. It's exciting that our commitment to excellence is rewarded, and that they have expanded the contract and renewed for a four year term," said Dan Martin, Chief Executive Officer of Innovest. "Bill Oler and his team continue to set the bar high, and we would not have grown at such a tremendous rate in 2018 without them. They are highly regarded professionals with decades of experience, and it shows."

About Innovest Global, Inc.
Innovest Global, Inc. (OTC Markets: IVST) is a conglomerate with operations in three divisions, which include commercial and industrial products and services, energy, biotechnology, health sciences, construction, and building materials. The primary growth strategy of Innovest Global Inc is to acquire existing companies in a select few industries and attract new customers in cost effective ways. Currently, Innovest Global Inc has a Commercial & Industrial Division, a Biotechnology & Health Services Division, and a Construction & Building Materials Division.

For more information, please visit: http://www.innovestglobal.com, and follow us on Twitter and Facebook @innovestglobal.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the OTC Markets. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Contact Information
Corporate Office:
(216) 815-1122
info@innovestglobal.com
Twitter @innovestglobal

Investor Relations:
Hayden IR
(917) 658-7878
hart@haydenir.com

For more information on this press release visit: http://www.releasewire.com/press-releases/innovest-global-signs-top-ohio-hospital-four-year-contract-1093124.htm

Innovest Energy Group had it’s best month ever with $250,000 in new contracts and six figures of revenue; their Call Center had it’s best Month in company history signing $508,000 in new contracts and their Safety Supply Group delivered on it’s first US Navy contract generating $150,000 in revenue.

Cleveland, OH -- (ReleaseWire) -- 11/16/2018 -- Innovest Global Inc. (OTC Markets:IVST) (the "Company" or "Innovest"), a conglomerate with operations in commercial and industrial products and services, biotechnology, and construction & building materials, is happy to recap the tremendous success in October and the first week of November. The company opened a new global headquarters; held a stockholder open house; closed an acquisition; announced a new eight-figure LOI; Innovest Energy Group had it's best month ever with $250,000 in new contracts and six figures of revenue; our Call Center had it's best Month in company history signing $508,000 in new contracts; our Safety Supply Group delivered on it's first US Navy contract generating $150,000 in revenue.

Innovest Global moved into its new world headquarters on October 1st making it the only publicly traded company in Geauga County Ohio!

The company closed the acquisition of Authority National Supply (ANS), which has generated $22.8 million in revenue through the first three quarters of 2018, after $24.5 million in annual revenue in 2017. ANS was IVST's sixth acquisition to-date.

We announced that the company has entered into a LOI to acquire Midwest Curtainwalls, which currently has an annual revenue run-rate of $12 million.

Shepherd Energy had its best month in history recording $250,000 in new contracts and six figures in revenue.

Contact Source Solutions hired 10 new people and was awarded new contracts totaling $508,000 in annual billing adding to it's previous $600,000 annual contract.

Chagrin Safety Supply delivered an order worth $150,000 to the US Navy, which is the companies First Navy contract.

Innovest Global Inc also submitted two (2) years of PCAOB Audited financials and began providing disclosures to OTC Markets, which are requirements for application to the OTCQB Venture Market trading platform for IVST, currently trading on the OTC Pink Market.

After selling Shepherd Energy to Innovest, Damon Mintz first advanced to Division President and has now referred and managed successful acquisitions across multiple divisions. Chairman and Chief Executive Officer, Dan Martin, has this to say, "We continue to evolve roles to best serve the company and certainly Damon is leading the charge not only with continued record sales growth, and with his 'Source of Strength' initiative we implemented earlier this year, but also on our acquisitions such as ANS, and our company positioning. He understands Innovest intuitively and has the personal characteristics to execute with the level of speed, excellence, and attention to detail, required by our growth and appreciated by our stockholders. He is a high integrity person who is focused on growth like few people I have ever seen, and a natural fit for the President role as we continue our exponential growth."

Mr. Mintz was recapping results and potential acquisition targets, and stated, "We are very excited about our newly announced LOI to acquire Midwest Curtainwalls and continue to be encouraged by the strong organic growth of our exiting holdings. The addition of ANS to the IVST family of companies has also opened the door to several other opportunities in the building supply distribution industry. Its great to be in business with great people! We continue to benefit from amazing people choosing to be part of the Innovest team".

About Innovest Global, Inc.
Innovest Global, Inc. (OTC Markets: IVST) is a conglomerate with operations in three divisions, which include commercial and industrial products and services, energy, biotechnology, health sciences, construction, and building materials. The primary growth strategy of Innovest Global Inc is to acquire existing companies in a select few industries and attract new customers in cost effective ways. Currently, Innovest Global Inc has a Commercial & Industrial Division, a Biotechnology & Health Services Division, and a new Construction & Building Materials Division.

For more information, please visit: http://www.innovestglobal.com, and follow us on Twitter and Facebook @innovestglobal.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the OTC Markets. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Contact Information
Corporate Office:
(216) 815-1122
info@innovestglobal.com
Twitter @innovestglobal

Investor Relations:
Hayden IR
(917) 658-7878
hart@haydenir.com

For more information on this press release visit: http://www.releasewire.com/press-releases/innovest-global-successfully-closes-october-its-highest-monthly-1087193.htm

Innovest now has approximately 55 employees and $34 million in annual run-rate revenue

Cleveland, OH -- (ReleaseWire) -- 11/07/2018 -- Innvoest Global Inc. (OTCMARKETS:IVST)- This is an official request for media coverage regarding the following release. The company has seen 3000% growth in its stock and 900% growth in its revenue for the course of the year on an acquisition model. Innovest is requesting coverage on its business model and why it has worked so successfully for Innovest in 2018.

Innovest Global Inc. (OTC Markets: IVST) (the "Company" or "Innovest"), a conglomerate with operations in commercial and industrial products and services, energy, biotechnology, and health services, is pleased to announce that we closed the acquisition of Authority National Supply (ANS). ANS was our sixth transaction to date, and has generated $22.8 million in sales through the first three quarters of 2018. Innovest now has approximately 55 employees and $34 million in annual run-rate revenue. The ANS closing this morning, came two weeks after the first anniversary of Innovest's initial acquisition, in a year that has seen tremendous growth from a focused strategy.

"From the feedback I am getting, this transaction completes the validation of our business model in the eyes of our primary audience," said Innovest Chairman and Chief Executive Officer, Dan Martin. "Because our strategy is validated and we are getting the results we predicted, we are just getting started and can now work to scale this growth significantly."

This transaction exemplifies the Innovest model, which emphasizes good people and good businesses: In early 2018 Innovest acquired Shepherd Energy, which was run by Damon Mintz. Then, Shepherd performed commercial lighting work for ANS that was executed with excellence. ANS was so pleased, that their CEO (Tony Crookston) struck up a relationship with Mr. Mintz, who shared how happy Shepherd was having been acquired by Innovest. Mr. Crookston was intrigued, brought the concept to his team, and found it to be a perfect fit for their growth model. With Mr. Mintz leading the acquisition on behalf of Innovest, and Mr. Crookston making the case for the value ANS could bring to Innovest, the acquisition is now final. "The outside world sees a big headline," said Mr. Martin, "But success is a series of little things done well. Our Energy Group sales team, the guys that installed the lighting, our quality control follow-up team, all of these people that did little things well are the ones that made that big headline. The leadership of Damon Mintz shined from end to end, and these are the reasons why the most important asset Innovest can have is good people."

Innovest extends a special thanks to our counsel Christopher Hubbert at Kohrman Jackson & Krantz, the twenty owners of ANS, and their counsel Aaron Lepp at Stark & Knoll for his navigating a complex transaction among many parties. Look for much more to come soon on this exciting effort!

About Innovest Global, Inc.
Innovest Global, Inc. (OTC Markets: IVST) is a conglomerate with operations in commercial and industrial products and services, energy, biotechnology, and health services. Our primary growth strategy is to acquire existing companies in a select few industries, and attract new customers in cost effective ways. Currently, we have a Commercial & Industrial Division, a Biotechnology & Health Services Division, and our new Construction & Building Materials Division.

For more information, please visit: http://www.innovestglobal.com, and follow us on Twitter and Facebook @innovestglobal.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the OTC Markets. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Contact Information
Corporate Office:
(216) 815-1122
info@innovestglobal.com
Twitter @innovestglobal

Investor Relations:
Hayden IR
(917) 658-7878
hart@haydenir.com

For more information on this press release visit: http://www.releasewire.com/press-releases/innovest-global-closes-acquisition-authority-national-supply-1081816.htm

The Commercial & Industrial Division continues to grow with September being the second highest monthly sales achievement this year, at $369K, marking $1,064,000 in third quarter revenue for the division, with $857K in current assets

Cleveland, OH -- (ReleaseWire) -- 10/25/2018 -- Innovest Global Inc. (USOTC:IVST), Commercial & Industrial Division continues to grow with September being the second highest monthly sales achievement this year, at $369K, marking $1,064,000 in third quarter revenue for the division, with $857K in current assets and zero long-term debt. There are several major items to report:

The Board of 'Authority National Supply' approved their pending company sale to IVST by Super Majority Vote, representing approximately $30 million in new annual revenue to Innovest.

On Friday October 19th we released our 2017 and 2016 independent auditors report. The report verifies financial results for 2017 and 2016 by an independent auditor to PCAOB standards. We are now preparing to file a 'Form 10' to register our security with the Securities and Exchange Commission.

Shepherd Energy, an Innovest Company, signed two new sales contracts for the DCR100 technology solution (a new technology we announced and launched earlier this year). These contracts will represent $349,000 in revenue for the company.

A new contract for Contact Source Solutions was signed indicating approximately $600,000 in annual billing. Contact Source Solutions has added an additional 10 new employees as a result of contract. On 9/21/18 the client asked for 5 seats & then added another 5, we have now filled all 10 and are in full billable production.

Chagrin Safety Supply, an Innovest Company, won a bid and then delivered a shipping container full of HAZMAT boots to the United States Navy 10 days ahead of schedule, weighing in at 18,000 pounds.
Yesterday marked the one-year anniversary of the first acquisition for Innovest, Chagrin Safety Supply. At that time Innovest went from zero revenue, to approximately $500,000 in annual revenue and since had five subsequent acquisitions, which have resulted in a proven business model and significant revenue growth.
Our ribbon cutting ceremony and open house takes place tomorrow, October 25th. We will be joined by members of the press, customers, friends, the community and potential acquisition candidates.

Our open house officially celebrates our new world headquarters in Geauga County, Ohio. The 13000 ft will serve as our world headquarters and is now home to several of our subsidiaries.

"I could not be more proud of our people, from our contract installation crews, to our call center representatives, marketing team, our acquisition team everyone continues to execute at a very high level. The company is laser-focused, on what used to be general long-term goals, but are now specific and right in front of us. I am very excited about how Innovest is positioned right now," said Dan Martin, Innovest's Chairman and Chief Executive Officer.

About Innovest Global, Inc.
Innovest Global, Inc. (USOTC : IVST) is in the Conglomerates industry, a diversified holding company with operations in commercial and industrial products and services, energy, biotechnology, and health services. Our primary growth strategy is to acquire existing companies in a select few industries, and attract new customers in cost effective ways. Currently, we have a Commercial & Industrial Division, a Biotechnology & Health Services Division, and our new Building Materials Division.

For more information, please visit: http://www.innovestglobal.com, and follow us on Twitter and Facebook @innovestglobal.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the OTC Markets. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Contact Information
Corporate Office:
(216) 815-1122
info@innovestglobal.com
Twitter @innovestglobal

Investor Relations:
Hayden IR
(917) 658-7878
hart@haydenir.com

For more information on this press release visit: http://www.releasewire.com/press-releases/innovest-global-october-update-features-strong-revenue-several-1073801.htm

In 2017, ANS generated $24.5 million in revenue, This transaction increases Innovest’s annual revenue by over 500%

Cleveland, OH -- (ReleaseWire) -- 10/23/2018 -- Innovest Global Inc. (OTCMarkets:IVST) (the "Company" or "Innovest"), announces that the previously announced 'Letter of Intent' to acquire a $30 million revenue generating company has been voted on in final form by that company and approved. Innovest Global will now enter the Building Materials industry with the purchase of Authority National Supply (ANS). The ANS Board of Directors voted to approve the transaction after receiving a super majority approval from its members. Innovest will ceremonially close the acquisition on Thursday, October 25th at 5 PM EST to kick-off our previously scheduled open house. In 2017, ANS generated $24.5 million in revenue. This transaction increases Innovest's annual revenue by over 500% (five-hundred percent).

This transaction gives Innovest and Ohio based Authority National Supply (ANS) a prime opportunity to quickly add revenue in the growing building materials industry. Tony Crookston, ANS Chief Executive Officer, stated, "Taking ANS public with the Innovest model is exactly the tool I need to capitalize on the tremendous opportunities ANS has to grow." In addition to being a group purchase organization (GPO) with a large pipeline of new potential business, ANS has an acquisition model, which Mr. Crookston intends to pursue aggressively, "We have twenty member-owners which are also owners of building materials businesses across the country. Let that sink in for how quickly I believe we can grow this division. Innovest just got started. We evaluated Innovest's modest revenue and current valuation, compared to how much we believe that value will increase over time with us on the team. It was a no-brainer for our owners to take a stock deal, and lock arms with Innovest to make that growth a reality. Damon Mintz worked extensively with our owners to make this transaction a reality, and I am ecstatic to work with him and the Innovest team led by their CEO Dan Martin, to make this new Innovest division a dominant player in the building materials industry."

"Tony is highly respected in the building materials industry. He is an amazing leader with a clear vision for growth, as indicated by the success of ANS and their large board of directors running successful businesses. He's one of the most focused and determined people I have ever met," said Dan Martin, Innovest's Chairman and Chief Executive Officer. "Damon Mintz, running our acquisition team and organic growth efforts, continues to set the bar for our growth and put us in a position to exceed our goals. This is a great moment for Innovest."

ANS informed Innovest on Friday October 19th that it had reached the supermajority vote required to complete the transaction. Both parties agreed that Innovest's upcoming Thursday evening open house at the new world headquarter facility, was a perfect opportunity to schedule a closing ceremony and celebration. Details of this transaction were announced by Innovest, on August 31, 2018, and look for more to come soon!

About Innovest Global, Inc.
Innovest Global, Inc. (OTC Markets: IVST) is in the Conglomerates industry, a diversified holding company with operations in commercial and industrial products and services, energy, biotechnology, and health services. Our primary growth strategy is to acquire existing companies in a select few industries, and attract new customers in cost effective ways. Currently, we have a Commercial & Industrial Division, a Biotechnology & Health Services Division, and our new Building Materials Division.

For more information, please visit: http://www.innovestglobal.com, and follow us on Twitter and Facebook @innovestglobal.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the OTC Markets. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Contact Information
Corporate Office:
(216) 815-1122
info@innovestglobal.com
Twitter @innovestglobal

Investor Relations:
Hayden IR
(917) 658-7878
hart@haydenir.com

For more information on this press release visit: http://www.releasewire.com/press-releases/authority-national-supply-board-approves-pending-company-sale-to-ivst-by-super-majority-vote-boosting-innovest-globals-revenue-by-30-million-annually-1070882.htm

The Audit report verifies financial results for 2017 and 2016 by an independent auditor

Cleveland, OH -- (ReleaseWire) -- 10/19/2018 -- Innovest Global Inc. (OTC Markets:IVST), has released its 2017 and 2016 independent auditors report. The report verifies financial results for 2017 and 2016 by an independent auditor, who states, "In our opinion, the financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2017 and 2016, and the results of its operations and its cash flows for each of the years in the periods ended December 31, 2017 and December 31, 2016, in conformity with accounting principles generally accepted in the United States of America."

The statements also detail 2018 material subsequent events including all of the acquisitions Innovest has announced this year, to date.

"These verified financial results will serve as the first domino for our growth model. They demonstrate our results to prospective acquisition partners and investors. Importantly, the completed audit is a key requirement of the uplisting process that we have consistently noted is part of our long term plan," said Dan Martin, Innovest's Chairman and Chief Executive Officer.

NMS Inc., a longstanding Ohio accounting firm conducted the independent audit to PCAOB (Public Company Accounting Oversight Board) standards. Those standards require the auditor to plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement. The financial statements and the complete report, as well as all Innovest disclosures are available by searching the trading symbol "IVST" on www.otcmarkets.com.

New Deals Signed:

- Shepherd Energy, An Innovest Company, signs two new sales of the DCR100 solution. These sales will add $349,000 in revenue.

- A new contract for Contact Source Solutions amounts to $600,000+/- in billing. Contact Source Solutions added 10 new employees.

About Innovest Global, Inc.
Innovest Global, Inc. (OTC Markets: IVST) is in the Conglomerates industry, a diversified holding company with operations in commercial and industrial products and services, energy, biotechnology, and health services. Our primary growth strategy is to acquire existing companies in a select few industries, and attract new customers in cost effective ways. Currently, we have a Commercial & Industrial Division, a Biotechnology & Health Services Division, and our new Building Materials Division launching soon.

For more information, please visit: http://www.innovestglobal.com, and follow us on Twitter and Facebook @innovestglobal.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with OTC Markets. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Contact Information
Corporate Office:
(216) 815-1122
info@innovestglobal.com
Facebook, Instagram, Twitter @innovestglobal

Investor Relations:
Hayden IR
(917) 658-7878
hart@haydenir.com

For more information on this press release visit: http://www.releasewire.com/press-releases/innovest-global-inc-otcmarketsivst-closes-audit-signs-949000-in-new-deals-and-adds-10-employees-1069545.htm

Innovest Global has established revenue from commercial and industrial clients, several months of record sales, contracts with Fortune 500 clients, a Biotech division, and a pending acquisition which is generating $30 million in sales.

Cleveland, OH -- (ReleaseWire) -- 09/27/2018 -- Innovest Global, Inc. (OTCMarkets:IVST) is in the Conglomerates industry, a diversified holding company with operations in commercial and industrial products and services, energy, biotechnology, and health services. Our primary growth strategy is to acquire existing companies in a select few industries, and attract new customers in cost effective ways. Currently, we have a Commercial & Industrial Division, and a Biotechnology & Health Services Division. Innovest Global Inc is Working On Closing A Major Building Materials Acquisition, Weekly Technicals Look Bullish.

The Cleveland, Ohio-based conglomerate continues to rapidly expand thanks to key acquisitions and thriving organic sales growth. Innovest Global, Inc. currently is experiencing a combination of strong fundamentals and technicals. The company's Commercial & Industrial Division has been a revenue machine for Innovest, as the division now is on track for annual revenue run-rate of $4.5 million.

The company's Biotech & Health Sciences Division is not currently generating revenue, but the division has a very bright future ahead. Lead by world-renowned neuroscientist, Dr. Dwain Morris-Irvin, the Biotech & Health Sciences Division is currently focused on commercializing StemVax Therapeutics' cancer vaccination therapy technology. The cancer vaccination therapy technology was just recently awarded a U.S. patent.

Innovest Global management team has been extremely busy with its pending mega-acquisition of a building materials company, which produces $30 million in annual revenues. Once the building materials company is acquired, it will serve as Innovest Global's third division. Management estimates that the building materials target acquisition could close sometime in early September 2018.

Management has detailed the serious of events that has took place earlier this year between Innovest and the target building materials company. The initial discussions began back in March 2018, followed by formal negotiations in April 2018.

In June, Innovest management formally proposed the acquisition pitch to the target company's board of directors. Upon conclusion of the presentation, both parties had signed and executed a Letter of Intent (LOI) document.

In late August 2018, it was announced that both parties have effectively reached an agreement on the acquisition transaction structure and long form documents. Under the agreed terms, Innovest will acquire 100% ownership of the target entity and will issue 5 million common shares (restricted) and a high-five figure cash payment in exchange.

"This transaction represents a substantial, over five-times increase in Innovest's revenue, and marks entry into its third industry sector. This is a transformational acquisition for Innovest. Because of the revenue, but also because the leadership of the organization is world class, well respected in their industry, and has a vision and plan for growth that I believe is highly likely to succeed in our model once we hit the switch," detailed Innovest Global CEO Dan Martin.

In other news, the biotech division, led by Dr. Dwain Morris-Irvin, will be attending the 48thAnnual Society for Neuroscience Conference and the BIO Investor Forum. The Society for Neuroscience will take place between November 3-7 in San Diego, California. The BIO Investor Forum will be held in San Francisco, California between October 17-18.

Innovest Global will be featured in Delta Sky Magazine's October Biotech Special Edition issue. The Delta Sky Magazine is the official in-flight magazine for Delta Air Lines, Inc. and has readership of around six million highly-engaged passengers.

Investors and traders looking to filter out the noise and the short-term should utilize weekly and monthly charts. These tend to provide a clearer picture of the current state of the stock and where it could be possibly heading in the coming weeks or months.

About Innovest Global, Inc.
Innovest Global, Inc. (OTC Markets: IVST) is in the Conglomerates industry, a diversified holding company with operations in commercial and industrial products and services, energy, biotechnology, and health services. Our primary growth strategy is to acquire existing companies in a select few industries, and attract new customers in cost effective ways. Currently, we have a Commercial & Industrial Division, and a Biotechnology & Health Services Division.

For more information, please visit: http://www.innovestglobal.com, and follow us on Twitter and Facebook @innovestglobal.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the OTC Markets. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Contact Information
Corporate Office:
(216) 815-1122
info@innovestglobal.com
Twitter and Facebook @innovestglobal

Investor Relations:
Hayden IR
(917) 658-7878

For more information on this press release visit: http://www.releasewire.com/press-releases/innovest-global-inc-working-on-closing-major-30000000-building-materials-acquisition-delta-sky-magazines-october-biotech-featured-article-being-published-1055606.htm

Innovest Global is preparing to close a large acquisition, working on the Form 10 to register IVST stock with the Securities and Exchange Commission and finalizing an audit with an independent auditor

Cleveland, OH -- (ReleaseWire) -- 09/21/2018 -- Innovest Global Inc. (OTCMarkets:IVST) (the "Company" or "Innovest"), is executing multiple initiatives at the corporate level which will result in the platform it needs for the next season of growth.

Innovest is preparing to transform from its fledgling startup roots earlier this year when it was a four-employee company with a few thousands of dollars of revenue and a 2 cent stock, which was trading under a "Limited Information" designation. The addition of 41 more employees and $4 million in run rate revenue, and a "Pink Current" trading designation led to a host of developments and a recent stock price in the twenty-cent range.

Now, the company has established revenue from commercial and industrial clients, several months of record sales, contracts with Fortune 500 clients, a Biotech division, and a pending acquisition which is generating $30 million in sales.

To accommodate the growth and give the company the ability to continue to grow and be effective, Chief Executive Officer Dan Martin has been busy staying ahead of the wave. "The business model works, its scalable, we don't have to compromise and we are focused on doing what we need to do to be a NYSE or NASDAQ company." Mr. Martin said, "We've got great people working very hard, on projects that are all related and finishing up at the same time. All geared toward staying high performance and being ready to be a much larger company."

Innovest is preparing to move into a 13,000 square foot headquarters in the heart of Geauga County. The property is the former headquarters of a $2.5 billion NYSE company, Geauga's only other public company, and was referred by the Geauga Growth Partnership. The terms were very attractive and costs mostly offset by the savings of bringing some of the acquired entities under one roof. "We are working really well together," said Division President, Damon Mintz, "This is a brilliant move to supercharge our sales efforts and is already creating a lot of buzz, and a lot of opportunity. Particularly with our new business development team."

Additionally, the team is preparing to close a large acquisition, working on the Form 10 to register IVST stock with the Securities and Exchange Commission, finalizing an audit with independent auditor NMS Inc. (Ohio registered PCAOB firm), working with HaydenIR on institutional investor strategies, and preparing disclosures for the application process required of the OTCQB exchange uplist process. Mr. Martin stated, "A lot of these items tie together, and were initiated several months ago, so there are a lot of moving parts and everyone is doing a wonderful job. We're getting things done right and making sure we know how much we appreciate everyone's hard work and patience while moving at this rapid pace."

Innovest is working toward an ultimate uplist "graduation" to NYSE or NASDAQ, but that requires more revenue, a share price in the several dollar range, more shareholders, and other items. All of which, Mr. Martin has intently focused the team on achieving. Look for much more to come soon on these and other initiatives.

About Innovest Global, Inc.
Innovest Global, Inc. (OTC Markets: IVST) is in the Conglomerates industry, a diversified holding company with operations in commercial and industrial products and services, energy, biotechnology, and health services. Our primary growth strategy is to acquire existing companies in a select few industries, and attract new customers in cost effective ways. Currently, we have a Commercial & Industrial Division, and a Biotechnology & Health Services Division.

For more information, please visit: http://www.innovestglobal.com, and follow us on Twitter and Facebook @innovestglobal.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the OTC Markets. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Contact Information
Corporate Office:
(216) 815-1122
info@innovestglobal.com
Twitter and Facebook @innovestglobal

Investor Relations:
Hayden IR
(917) 658-7878
hart@haydenir.com

For more information on this press release visit: http://www.releasewire.com/press-releases/innovest-global-inc-otcmarketsivst-is-executing-multiple-initiatives-1052194.htm

Innovest Global Inc. is hosting over twenty energy professionals as the Innovest Energy Group pushes forward with its growth plan.

Cleveland, OH -- (ReleaseWire) -- 09/19/2018 -- Innovest Global Inc. (OTCMarkets:IVST) (the "Company" or "Innovest"), hosted over twenty energy professionals as the Innovest Energy Group pushes forward with its growth plan.

Over the past six months since they were acquired, Shepherd Energy and HP Technologies have worked together with satellite offices, and brought to market Energy items such as the LEEP financing program, and DCR demand cost reduction units. These companies have been the first beneficiaries of the "Source of Strength" best practices led by Commercial & Industrial Division President, Damon Mintz, in which Innovest seeks to support, grow, and be a strategic resource for acquired entities. Results are solid organic growth post-acquisition. Today's meetings will focus on new sales efforts, training, and goals.

"Our success formula is simple," said Dan Martin, Innovest's Chief Executive Officer. "We acquire good businesses with solid leadership and a real growth plan, and we want them to be better for having joined us." So far that has been the case, and the people who have sold businesses to Innovest have all been very happy with the decision. "As an early acquisition, my partners and I are not only thrilled with the value we received and how it is growing, but have found that working with other like minded owners has really expanded our expectations for success," said Mr. Mintz. "The enthusiasm and drive is contagious."

One primary Energy Group development is that industry pioneer Dennis Giancola, H.P.'s founder, is now managing procurement for all Commercial Energy clients. Dennis was Ohio's first independent commercial energy broker. He is a Board Member of Energy Professionals of Ohio. His background is in energy efficiency, and through H.P., Innovest is licensed for both gas and electric in all deregulated states. "The respect that Dennis has earned within our industry and among his peers, is without equal," said Mr. Mintz. "He is exactly the person we need, to take full advantage of the opportunities before us."

Mr. Giancola is equally enthusiastic, and addressed his enthusiasm back in March. "This is an unprecedented time of opportunity in the Energy business," he said. "I'm determined and frankly, fired-up, to be part of a team that is so focused, and so well equipped to go after it." The team has been going after it ever since, and looks forward to proving many positive updates as they finish the year.

About Innovest Global, Inc.
Innovest Global, Inc. (OTC Markets:IVST) is in the Conglomerates industry, a diversified holding company with operations in commercial and industrial products and services, energy, biotechnology, and health services. Our primary growth strategy is to acquire existing companies in a select few industries, and attract new customers in cost effective ways. Currently, we have a Commercial & Industrial Division, and a Biotechnology & Health Services Division.

For more information, please visit: http://www.innovestglobal.com, and follow us on Twitter and Facebook @innovestglobal.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the OTC Markets. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Contact Information
Corporate Office:
216-815-1122
info@innovestglobal.com
Twitter @innovestglobal

Investor Relations:
Hayden IR
917-658-7878
hart@haydenir.com

For more information on this press release visit: http://www.releasewire.com/press-releases/innovest-global-inc-otcmarketsivst-advances-strategic-growth-plan-for-innovest-energy-group-1050559.htm

Innovest Global Inc (OTC:IVST) is up 1100% YTD And Has a $30,000,000 Revenue Pending Acquisition

Cleveland, OH -- (ReleaseWire) -- 09/13/2018 -- Spotlight Growth has published new content on Innovest Global, Inc. (OTC PINK: IVST). Innovest Global, Inc. is a diversified holding company that focuses on acquiring niche, high-growth businesses that are capable of generating significant annual revenue. The company's planned subsidiaries operate across telehealth, biotech, building materials, commercial energy, business-to-business distribution, national call center and auto sales.

The report provides an overview of Innovest Global, Inc., its subsidiaries, financials, US construction industry analysis, global construction industry analysis, building materials, biotech and more.

ResearchAndMarkets: U.S. Construction Market Forecast To Reach $1.77 Trillion By 2022

Construction activity can serve as a litmus test for the health of the overall economy. During times of economic expansion, construction activity is largely robust and active. Meanwhile, downturns tend to slow or nearly halt construction activity.

According to ResearchAndMarkets, the United States construction industry is expected to see a compound annual growth rate (CAGR) of 7.60% between 2018 and 2022. The market research group notes that residential construction increased at a CAGR of 11.4% between 2013-2017. Commercial construction increased at a CAGR of 10.9% during 2013-2017.

According to Statista, United States construction expenditures came in around $1.23 trillion in 2017. The market research firm estimates that U.S. construction spending will increase from $1.23 trillion in 2017 to $1.53 trillion in 2022.

According to the Construction Intelligence Center (CIC), the global construction industry is expected to have strong performance over the next several years as well.

In December 2017, the CIC released report forecasting that the global construction industry will see growth of 3.6% between 2018 and 2022. However, the CIC released an updated report in April 2018, which increased its growth estimate to 3.7% between 2018 and 2022.

While this may not seem like much at first glance, "in real value terms (measured at constant 2017 prices and US$ exchange rates), global construction output is forecast to rise to US$12.4 trillion in 2022 from US$10.4 trillion in 2017," according to the report.

IVST: Working On Closing Major Building Materials Acquisition, Weekly Technicals Look Bullish

The Cleveland, Ohio-based conglomerate continues to rapidly expand thanks to key acquisitions and thriving organic sales growth. Innovest Global, Inc. currently is experiencing a combination of strong fundamentals and technicals. The company's Commercial & Industrial Division has been a revenue machine for Innovest, as the division now is on track for annual revenue run-rate of $4.5 million.

The company's Biotech & Health Sciences Division is not currently generating revenue, but the division has a very bright future ahead. Lead by world-renowned neuroscientist, Dr. Dwain Morris-Irvin, the Biotech & Health Sciences Division is currently focused on commercializing StemVax Therapeutics' cancer vaccination therapy technology. The cancer vaccination therapy technology was just recently awarded a U.S. patent.

Innovest Global management team has been extremely busy with its pending mega-acquisition of a building materials company, which produces $30 million in annual revenues. Once the building materials company is acquired, it will serve as Innovest Global's third division. Management estimates that the building materials target acquisition could close sometime in early September 2018.

Management has detailed the serious of events that has took place earlier this year between Innovest and the target building materials company. The initial discussions began back in March 2018, followed by formal negotiations in April 2018.

In June, Innovest management formally proposed the acquisition pitch to the target company's board of directors. Upon conclusion of the presentation, both parties had signed and executed a Letter of Intent (LOI) document.

In late August 2018, it was announced that both parties have effectively reached an agreement on the acquisition transaction structure and long form documents. Under the agreed terms, Innovest will acquire 100% ownership of the target entity and will issue 5 million common shares (restricted) and a high-five figure cash payment in exchange.

"This transaction represents a substantial, over five-times increase in Innovest's revenue, and marks entry into its third industry sector. This is a transformational acquisition for Innovest. Because of the revenue, but also because the leadership of the organization is world class, well respected in their industry, and has a vision and plan for growth that I believe is highly likely to succeed in our model once we hit the switch," detailed Innovest Global CEO Dan Martin.

In other news, the biotech division, led by Dr. Dwain Morris-Irvin, will be attending the 48thAnnual Society for Neuroscience Conference and the BIO Investor Forum. The Society for Neuroscience will take place between November 3-7 in San Diego, California. The BIO Investor Forum will be held in San Francisco, California between October 17-18.

Innovest Global will be featured in Delta Sky Magazine's October Biotech Special Edition issue. The Delta Sky Magazine is the official in-flight magazine for Delta Air Lines, Inc. and has readership of around six million highly-engaged passengers.

Investors and traders looking to filter out the noise and the short-term should utilize weekly and monthly charts. These tend to provide a clearer picture of the current state of the stock and where it could be possibly heading in the coming weeks or months.

If we take a look at a weekly chart of IVST, we see several positives currently:

-Current weekly candle at the high

-50 day moving average (green) trading above 100 day moving average (red)

-MACD shows bear position very weak, looking ripe for a bullish crossover in coming week or two

-Stochastics trending higher, currently around 60 (not overbought or oversold)

Innovest Global was recently featured on an episode of Spotlight Growth Live, a video web-series highlighting emerging growth companies. To view the video, please visit: http://spotlightgrowth.com/index.php/video/

For more information on Innovest Global, Inc., please visit http://innovestglobal.com and http://spotlightgrowth.com/index.php/2018/09/12/innovest-global-inc-otc-pink-ivst-a-diversified-conglomerate-with-strong-fundamental-and-technical-analysis/

SpotlightGrowth.com is a digital hub for micro-caps, small-caps, crowdfunding, cryptocurrency, and other emerging growth investors. SpotlightGrowth.com serves as our media subsidiary and provides insights on small cap companies.

Disclaimer:

Spotlight Growth is compensated, either directly or via a third party, to provide investor relations services for its clients. Spotlight Growth creates exposure for companies through a customized marketing strategy, including design of promotional material, the drafting and editing of press releases and media placement.

All information on featured companies is provided by the companies profiled, or is available from public sources. Spotlight Growth and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. The information contained herein is based on external sources that Spotlight Growth believes to be reliable, but its accuracy is not guaranteed. Spotlight Growth may create reports and content that has been compensated by a company or third-parties, or for purposes of self-marketing. Spotlight Growth was compensated two thousand five hundred dollars cash and fifty thousand restricted shares for the creation and dissemination of this content.

This material does not represent an investment solicitation. Certain statements contained herein constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may include, without limitation, statements with respect to the Company's plans and objectives, projections, expectations and intentions. These forward-looking statements are based on current expectations, estimates and projections about the Company's industry, management's beliefs and certain assumptions made by management.

The above communication, the attachments and external Internet links provided are intended for informational purposes only and are not to be interpreted by the recipient as a solicitation to participate in securities offerings. Investments referenced may not be suitable for all investors and may not be permissible in certain jurisdictions.

Spotlight Growth and its affiliates, officers, directors, and employees may have bought or sold or may buy or sell shares in the companies discussed herein, which may be acquired prior, during or after the publication of these marketing materials. Spotlight Growth, its affiliates, officers, directors, and employees may sell the stock of said companies at any time and may profit in the event those shares rise in value. For more information on our disclosures, please visit: http://spotlightgrowth.com/index.php/disclosures/

Matt Rego
916-525-7147
mrego@spotlightgrowth.com

For more information on this press release visit: http://www.releasewire.com/press-releases/innovest-global-inc-strong-fundamental-technical-analysis-puts-1048073.htm

Innovest Global has announced a pending acquisition of a $30 million revenue company, which would mark its fifth acquisition of 2018

Cleveland, OH -- (ReleaseWire) -- 09/11/2018 -- Innovest Global Inc. (OTCMarkets:IVST) (the "Company" or "Innovest"), sales from its existing business units continue to grow, the Company now owns a 20% stake in StemVax Therapeutics, which has the worldwide exclusive rights to a brain cancer vaccine, which is patent protected. Innovest has announced a pending acquisition of a $30 million revenue company, which would mark its fifth acquisition of 2018, and increase the Company's annual revenue to over five-times its current rate.

Innovest detailed the pending acquisition in an August 31 news release, which would enter it solidly into the Building Materials industry with $30 million in annual revenue, and a growth plan. Details included a months-long process that resulted in a signed Letter of Intent, agreed final structure, and a closing expected in mid-September.

Earlier in August, the fall Biotech conference schedule was released. "With the recently announced patent approval, and obtaining exclusive worldwide rights to the technology, we believe that now is the time to collaborate with other scientists that have technologies which serve Innovest's mission and could benefit from the relationship," said Dr. Dwain Morris-Irvin, Biotech Division President and the StemVax founder. Dr. Morris Irvin and his team will be attending two conferences this fall: the Society for Neuroscience (SFN) 48th annual meeting, "Neuroscience 2018", November 3-7 in San Diego, CA, and the BIO Investor Forum October 17-18 in San Francisco, CA.

In August, efforts resulted in a feature article in the Los Angeles Business Journal, related to StemVax. Additionally, there is a feature scheduled in the Biotech edition of Delta Sky Magazine's October special Biotech edition, which has over six million highly engaged readers in prime demographic, and the company was thrilled that this Innovest update was unexpectedly selected by Release Wire, as the top front page article they ran with this weekend.

"We are transitioning from sharing what we 'plan to do' by paying for marketing exposure, to letting media know what we 'have done' and being a truly interesting company worthy of coverage. That's very exciting," said CEO Dan Martin. "As we tie up our first audit, uplist and new acquisition items in the coming days, and our security registration with the Securities and Exchange Commission thereafter, we will have planted as many seeds as possible for a large audience to see us for what we will have become – a legitimate, high growth publicly traded company doing meaningful things in a select few attractive industries."

To evolve the awareness strategy, Innovest recently engaged HaydenIR, an established investor relations firm, and earlier this month hired a VP of Marketing and Communications, Derek McCarthy, who has helped public companies navigate these items for the past ten years. The initial results speak for themselves.

Dan Martin summarized the process and his reasoning, "We had a nice start this year. Now we've got significant interest from institutional investors who help companies like Innovest grow, by providing large investments for acquisitions. It's our job to get those deals in place on the best possible terms for the company. Things like audits, and being SEC registered and uplisted, all reduce risk for investors, give us better terms, and expand the audience willing to hold Innovest stock. As does media coverage and public interest in general. There is nothing more important than our long-term execution, and nothing more important to shareholder value than the initial terms of big deals being attractive. I'm interested in our current stock price and happy with our gains this year, but I've got the team focused on taking time to do things right, and executing on the foundation of our long term strategy, so that those first big deals are great for shareholders and we head into 2019 with a strong foundation. It's an uncommon strategy for a pink sheet company, but I feel like our results in the market have shown that OTC investors are patient and appreciate our willingness to stand firm on long term focus and not cut corners to accommodate short term thinking. The media coverage efforts will be an invaluable part of this equation as we grow."

The Innovest C&I Division is diligently refining organic growth strategies. "Innovest is in discussions with meaningful acquisition targets, but those transactions only work long-term if we can grow them and help them succeed – and so far I couldn't be more impressed with Division President Damon Mintz, Sally Emch, Bill Oler, Dennis Giancola and the rest of our 40 people who are doing an incredible job right now," said Mr. Martin. His comments are echoed by the Innovest mission statement, which is, "To operate our business responsibly on a daily basis to maximize shareholder value and be a source of strength to our companies, helping them reach their fullest potential."

The Company's stock price grew 33.1% in August, from $.20 starting the month to closing August 31 at $.2663. Innovest maintains an unchanged free-trading float of 11,796,710 common shares with no convertible debts, no warrants or options outstanding, and employs 45.

About Innovest Global, Inc.
Innovest Global, Inc. (OTC Markets:IVST) is in the Conglomerates industry, a diversified holding company with operations in commercial and industrial products and services, energy, biotechnology, and health services. Our primary growth strategy is to acquire existing companies in a select few industries, and attract new customers in cost effective ways. Currently, we have a Commercial & Industrial Division, and a Biotechnology & Health Services Division.

Innovest owns 20% of StemVax Therapeutics which is the first company in it's Biotech Division.

StemVax Therapeutics is a Translational Biotechnology Company that develops novel therapies for brain tumor patients. We focus our efforts on developing immunotherapeutic approaches to treating patients with Glioblastoma Multiforme (GBM), a devastating brain cancer. We also focus our research efforts on novel drug development to target Cancer Stem cells and other multi-resistant cancer cells. We seek to make a difference in patient's lives. Bringing new beginnings to the market by developing novel therapeutics.

For more information, please visit: http://www.innovestglobal.com, and follow us on Twitter and Facebook @innovestglobal.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the OTC Markets. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Contact Information
Corporate Office:
216-815-1122
info@innovestglobal.com
Twitter @innovestglobal

Investor Relations:
Hayden IR
917-658-7878
hart@haydenir.com

For more information on this press release visit: http://www.releasewire.com/press-releases/innovest-global-inc-marks-its-fifth-acquisition-of-2018-and-is-poised-to-increase-its-annual-revenue-to-over-five-times-its-current-rate-with-a-pending-acquisition-of-a-30-million-revenue-company-1046856.htm

Innovest Global Inc. has signed a letter of intent, and agreed to final structure for the acquisition of a $30 million revenue company in the Building Materials Industry.

Cleveland, OH -- (ReleaseWire) -- 08/31/2018 -- Innovest Global Inc. (OTCMarkets:IVST) (the "Company" or "Innovest"), has signed a letter of intent, and agreed to final structure for the acquisition of a $30 million revenue company in the Building Materials Industry. This will add to its current operations in commercial and industrial products and services, and its recent biotech acquisition.

This transaction represents a substantial, over five-times increase in Innovest's revenue, and marks entry into its third industry sector. "This is a transformational acquisition for Innovest," said, Chief Executive Officer, Dan Martin. "Because of the revenue, but also because the leadership of the organization is world class, well respected in their industry, and has a vision and plan for growth that I believe is highly likely to succeed in our model once we hit the switch." Mr. Martin noted that the company has a unique model, which at the current sales rate is slightly profitable, and features low fixed costs and a growth strategy that projects increasing profits with significant sales growth. The target's leadership group views Innovest as the ideal platform from which to launch their growth plan. The Building Materials Industry outlook is very favorable overall, and is trending toward consolidation, both of which are attractive to Innovest.

Discussions began in March 2018. In April, formal negotiations began. Innovest formally presented to the board of directors of the target company on June 11th, which approved and executed a proposed Letter of Intent at that meeting. Yesterday, after over two months of negotiating the structure of the transaction, Innovest learned that both parties have agreed on the long form documents and structure of the transaction. Because the transaction represents such a significant revenue boost to Innovest, both parties maintained confidentiality throughout the process until final terms and language were acceptable. Details of the transaction, once completed, will be disclosed in Innovest's pending 2017 audit and forthcoming OTC Markets disclosures (as "Subsequent Events"). Both parties view the transaction as "very attractive". Terms include a 100% acquisition of the target entity in exchange for the issuance of 5 million common shares, restricted, with a minimum value guarantee to be achieved in two years, and a high five-figure cash payment at closing. Closing is expected in the first half of September. Look for much more information to come soon.

"Our team has been very focused on some very meaningful projects, for several months. We've put smaller opportunities on hold and focused our efforts on these key initiatives. We are working hard to finalize several of these priorities this quarter," said Mr. Martin. "We've got a talented team, who I appreciate immensely. We're having fun, working hard, and looking forward to the many exciting things ahead."

About Innovest Global, Inc.
Innovest Global, Inc. (OTCMarkets:IVST) is in the Conglomerates industry, a diversified holding company with operations in commercial and industrial products and services, energy, biotechnology, and health services. Our primary growth strategy is to acquire existing companies in a select few industries, and attract new customers in cost effective ways. Currently, we have a Commercial & Industrial Division, and a Biotechnology & Health Services Division.

Innovest owns 20% of StemVax Therapeutics which is the first company in its Biotech Division.

StemVax Therapeutics is a Translational Biotechnology Company that develops novel therapies for brain tumor patients. We focus our efforts on developing immunotherapeutic approaches to treating patients with Glioblastoma Multiforme (GBM), a devastating brain cancer. We also focus our research efforts on novel drug development to target Cancer Stem cells and other multi-resistant cancer cells. We seek to make a difference in patient's lives. Bringing new beginnings to the market by developing novel therapeutics.

For more information, please visit: http://www.innovestglobal.com, and follow us on Twitter and Facebook @innovestglobal.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the OTC Markets. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Contact Information
Corporate Office:
216-815-1122
info@innovestglobal.com
Twitter @innovestglobal

Investor Relations:
Hayden IR
917-658-7878
hart@haydenir.com

For more information on this press release visit: http://www.releasewire.com/press-releases/innovest-global-inc-otcivst-set-to-add-30-million-in-annual-revenue-with-pending-acquisition-1040396.htm

Innovest Global will be featured in the Biotech edition of Delta Sky Magazine’s October special Biotech edition, which has over six million highly engaged readers

Cleveland, OH -- (ReleaseWire) -- 08/28/2018 -- Innovest Global Inc. (OTCMarkets:IVST) (the "Company" or "Innovest"), a diversified holding company with operations in commercial and industrial products and services, energy, biotechnology and health services, is seeing results from its recent initiative to generate public interest in its accomplishments.

In August, efforts resulted in a feature article in the Los Angeles Business Journal, related to StemVax Therapeutics, a holding of our biotechnology division. Additionally, there is a feature scheduled in the Biotech edition of Delta Sky Magazine's October special Biotech edition, which has over six million highly engaged readers in prime demographic, and the company was thrilled that this Innovest update was unexpectedly selected by Release Wire, as the top front page article they ran with this weekend.

"We are transitioning from sharing what we 'plan to do' by paying for marketing exposure, to letting media know what we 'have done' and being a truly interesting company worthy of coverage. That's very exciting," said, Chief Executive Officer, Dan Martin. "As we tie up our first audit, uplist and new acquisition items in the coming days, and our security registration with the Securities and Exchange Commission thereafter, we will have planted as many seeds as possible for a large audience to see us for what we will have become – a legitimate, high growth publicly traded company doing meaningful things in a select few attractive industries."

To evolve the awareness strategy, Innovest recently engaged Hayden IR.com, an established investor relations firm, and earlier this month hired a VP of Marketing and Communications, Derek McCarthy, who has helped public companies navigate these items for the past ten years. The initial results speak for themselves.

Dan Martin summarized the process and his reasoning, "We had a nice start this year. Now we've got significant interest from institutional investors who help companies like Innovest grow, by providing large investments for acquisitions. It's our job to get those deals in place on the best possible terms for the company. Things like audits, and being SEC registered and uplisted, all reduce risk for investors, give us better terms, and expand the audience willing to hold Innovest stock.

As does media coverage and public interest in general. There is nothing more important than our long-term execution, and nothing more important to shareholder value than the initial terms of big deals being attractive. I'm interested in our current stock price and happy with our gains this year, but I've got the team focused on taking time to do things right, and executing on the foundation of our long term strategy, so that those first big deals are great for shareholders and we head into 2019 with a strong foundation. It's an uncommon strategy for a pink sheet company, but I feel like our results in the market have shown that our OTC investors are patient and appreciate our willingness to stand firm on long-term focus and not cut corners to accommodate short-term thinking. The media coverage efforts will be an invaluable part of this equation as we grow."

About Innovest Global, Inc.
Innovest Global, Inc. (OTC Markets:IVST) is in the Conglomerates industry, a diversified holding company with operations in commercial and industrial products and services, energy, biotechnology, and health services. Our primary growth strategy is to acquire existing companies in a select few industries, and attract new customers in cost effective ways. Currently, we have a Commercial & Industrial Division, and a Biotechnology & Health Services Division.

Innovest owns 20% of StemVax Therapeutics which is the first company in it's Biotech Division.

StemVax Therapeutics is a Translational Biotechnology Company that develops novel therapies for brain tumor patients. We focus our efforts on developing immunotherapeutic approaches to treating patients with Glioblastoma Multiforme (GBM), a devastating brain cancer. We also focus our research efforts on novel drug development to target Cancer Stem cells and other multi-resistant cancer cells. We seek to make a difference in patient's lives. Bringing new beginnings to the market by developing novel therapeutics.

For more information, please visit: http://www.innovestglobal.com, and follow us on Twitter and Facebook @innovestglobal.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the OTC Markets. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Contact Information
Corporate Office:
216-815-1122
info@innovestglobal.com
Twitter @innovestglobal

Investor Relations:
Hayden IR
917-658-7878
hart@haydenir.com

For more information on this press release visit: http://www.releasewire.com/press-releases/innovest-global-inc-otcmarketsivst-media-efforts-take-root-ahead-of-developments-as-they-tie-up-their-first-audit-uplist-and-new-acquisition-items-1036658.htm

The Biotechnology Division announced that it will be attending two conferences this fall to advance the objectives of StemVax Therapeutics, and to explore additional Biotech opportunities.

Cleveland, OH -- (ReleaseWire) -- 08/27/2018 -- Innovest Global Inc. (OTC Markets:IVST) (the "Company" or "Innovest") Biotechnology Division announced that it will be attending two conferences this fall to advance the objectives of StemVax Therapeutics, and to explore additional Biotech opportunities.

"With the recently announced patent approval, and obtaining exclusive worldwide rights to the technology, we believe that now is the time to collaborate with other scientists that have technologies which serve Innovest's mission and could benefit from the relationship," said Dr. Dwain Morris-Irvin, Division President and the StemVax founder.

Dr. Morris-Irvin and his team will attend the Society for Neuroscience (SFN) 48th annual meeting, "Neuroscience 2018", November 3-7 in San Diego, CA. It is the world's largest neuroscience conference for scientists and physicians devoted to understanding the brain and nervous system. SFN is a renowned venue for neuroscientists, where more than 30,000 colleagues from more than 80 countries collaborate and network with peers, learn from experts, explore the newest neuroscience tools and technologies, and discover great career opportunities.

They will also attend the BIO Investor Forum October 17-18 in San Francisco, CA. The BIO Investor Forum is an international biotech investor conference focused on early and established private companies as well as emerging public companies. The event features plenary sessions, business roundtables and therapeutic workshops, company presentations, and individual meetings.

About Innovest Global, Inc.
Innovest Global, Inc. (OTC Markets:IVST) is in the Conglomerates industry, a diversified holding company with operations in commercial and industrial products and services, energy, biotechnology, and health services. Our primary growth strategy is to acquire existing companies in a select few industries, and attract new customers in cost effective ways. Currently, we have a Commercial & Industrial Division, and a Biotechnology & Health Services Division.

Innovest owns 20% of StemVax Therapeutics which is the first company in its Biotech Division.

StemVax Therapeutics is a Translational Biotechnology Company that develops novel therapies for brain tumor patients. We focus our efforts on developing immunotherapeutic approaches to treating patients with Glioblastoma Multiforme (GBM), a devastating brain cancer. We also focus our research efforts on novel drug development to target Cancer Stem cells and other multi-resistant cancer cells. We seek to make a difference in patient's lives. Bringing new beginnings to the market by developing novel therapeutics.

For more information, please visit: http://www.innovestglobal.com, and follow us on Twitter and Facebook @innovestglobal.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein, are included in the Company's filings with the OTC Markets. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Contact Information
Corporate Office:
216-815-1122
info@innovestglobal.com
Twitter @innovestglobal

Investor Relations:
Hayden IR
917-658-7878
hart@haydenir.com

For more information on this press release visit: http://www.releasewire.com/press-releases/innovest-global-inc-otcmarketsivst-biotech-division-sets-fall-conference-schedule-1036693.htm

Innovest Global Highlights Key Accomplishments and Revenue Streams for August 2018

Cleveland, OH -- (ReleaseWire) -- 08/24/2018 -- Innovest Global Inc, (OTCMARKETS:IVST) A publicly traded operating company with diversified holdings in Commercial & Industrial, Energy, and Biotechnology & Health Services, Highlights is accomplishments for August 2018. The Company reports that their Call Center Revenue has doubled since the Acquisition, Shepherd Energy has landed a $100,000 Plus Contract, and the commercial and industrial Division Now Pacing $4,500,000 in Revenue.

The Innovest Biotech Division launched with the acquisition of a twenty percent stake in StemVax Therapeutics, and with the news that the primary technology for the StemVax brain tumor vaccine had been granted patent approval after a nine year filing process. Immediately following this news, StemVax was granted exclusive worldwide rights to this patent and three other technologies it will now use in its efforts to commercialize the vaccine.

Innovest Global previously announced that the Call Center signed a $650K+ Fortune 500 contract for providing call center services to Byram Healthcare Division was fully implemented, team trained and operational; "The Innovest team is highly professional, does an incredible job for us at the right price, and takes our business as seriously as we do," said Perry Bernocchi, Chief Executive Officer of Byram Healthcare. "To our customers, they are part of the Byram team, and they've proven we can rely on them to be a proud part of our family."

The Call Center is now generating double the baseline revenue it was generating just a few months ago, when it was acquired. The division is now pacing $4.5 million in annual revenue.

"Sally Emch, our President of Call Center Operations, has doubled the center's baseline revenue since the acquisition, and the Shepherd team just closed another six figure sale," said Dan Martin, CEO of Innovest. "The StemVax patent approval has been a recent focus of excitement, and our C&I Group is also really hitting stride. Working together well, closing big competitive sales, and excited to push through the quarter with momentum. The team is so excited at the support our shareholders have shown, and the enthusiasm is something I wish everyone could see."

The Innovest C&I Division is diligently refining organic growth strategies. "Innovest is in discussions with meaningful acquisition targets, but those transactions only work long-term if we can grow them and help them succeed - and so far I couldn't be more impressed with Division President Damon Mintz, Sally Emch, Bill Oler, Dennis Giancola and the rest of our 40 people who are doing an incredible job right now," said Mr. Martin. His comments are echoed by the Innovest mission statement, which is, "To operate our business responsibly on a daily basis to maximize shareholder value and be a source of strength to our companies, helping them reach their fullest potential."

Recent Notable Events:

First half 2018 revenue growth 55.8%
Current assets of $877,861
Cash balance of $561,062
Unchanged free-trading float of 11,796,710 common shares
No convertible debts, no warrants or options outstanding
Headcount is now 44 employees
Commercial & Industrial Division generated July monthly revenue of $351,763
Advanced an acquisition initiative on a top priority target, kept others in discussion, and finalized our second half plan

About Innovest Global, Inc.
Innovest Global, Inc. (OTCMarkets:IVST) is in the Conglomerates industry, a diversified holding company with operations in commercial and industrial products and services, energy, biotechnology, and health services. Innovest Global utilizes novel technology and marketing to efficiently acquire customers. Our primary growth strategy is to acquire existing companies in a select few industries, and attract new customers in cost effective ways. Currently, we have a Commercial & Industrial Division, and a Biotechnology & Health Services Division.

About StemVax Therapeutics
StemVax Therapeutics is a Translational Biotechnology Company that develops novel therapies for brain tumor patients. We focus our efforts on developing immunotherapeutic approaches to treating patients with Glioblastoma Multiforme (GBM), a devastating brain cancer. We also focus our research efforts on novel drug development to target Cancer Stem cells and other multi-resistant cancer cells. We seek to make a difference in patient's lives. Bringing new beginnings to the market by developing novel therapeutics. Dr. Dwain Morris-Irvin, President of Innovest's Biotech division is the StemVax founder and Chief Science Officer.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. All statements other than statements of historical facts included in this press release are forward-looking statements. These statements relate to future events or to the Company's future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Investors should not place any undue reliance on forward-looking statements since they involve known and unknown, uncertainties and other factors which are, in some cases, beyond the Company's control which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects the Company's current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to operations, results of operations, growth strategy and liquidity. Such risks, uncertainties and other factors, which could impact the Company and the forward-looking statements contained herein are included in the Company's filings with the OTC Markets. The Company assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

Contact Information
Corporate Office:
216-815-1122
info@innovestglobal.com
Twitter @innovestglobal

Investor Relations:
Hayden IR
917-658-7878
hart@haydenir.com

Source: Innovest Global, Inc

For more information on this press release visit: http://www.releasewire.com/press-releases/innovest-global-inc-announces-its-call-center-revenue-has-doubled-since-its-acquisition-shepherd-energy-seals-100k-plus-contract-ci-division-pacing-45mm-revenue-1035513.htm